CIK 0001851484 · <br>Emerging growth company
CITIUS ONCOLOGY, INC.
Sign in to watch- Ticker
- CTOR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 994362660
- Phone
- (908) 967-6677
- Business address
- 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
- Former names
- TenX Keane Acquisition
- 10-Q Report Quarterly Report
- 4 Other acquisition Director acquired 21,228 shares (other)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Other events
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- S-1 Offering Registration Statement
- 8-K Event Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- 8-K Event Delisting notice
- 8-K Event Material agreement
- DEFA14C Other DEFA14C
- DEF 14C Other DEF 14C
- 8-K Event Other events
Page 6 of 14 · 268 filings